secwatch.observer — SEC 8-K summary
======================================

Issuer:     CAPRICOR THERAPEUTICS, INC. (CAPR)
CIK:        0001133869
Form:       8-K
Filed at:   2025-12-03T23:59:59+00:00
Accession:  0001104659-25-117981
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Capricor provides HOPE-3 trial update via slide presentation, no new data disclosed
--------------------------------------------------------------------------------

- Filed Item 7.01 with slide presentation dated Dec 3, 2025 on HOPE-3 Phase 3 top-line results.
- Slide presentation contains no specific efficacy or safety numbers in the attached exhibit.
- Company held conference call; full slides available on investor website.
- No materially new financial or clinical information beyond prior top-line announcement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1133869/000110465925117981/0001104659-25-117981-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1133869/000110465925117981/capr-20251203x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-117981

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer